BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 19467961)

  • 1. [Prognostic impact of tumour volume and lymph node involvement in intermediate stage T1b1 to T2b cancer of the uterine cervix].
    Goudy G; Stoeckle E; Thomas L; Kind M; Guyon F; Brouste V; Floquet A
    Bull Cancer; 2009 Jun; 96(6):685-94. PubMed ID: 19467961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor volume and uterine body invasion assessed by MRI for prediction of outcome in cervical carcinoma treated with concurrent chemotherapy and radiotherapy.
    Kim H; Kim W; Lee M; Song E; Loh JJ
    Jpn J Clin Oncol; 2007 Nov; 37(11):858-66. PubMed ID: 18037686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
    Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
    Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation using magnetic resonance imaging for patients with stage III cervical carcinoma treated by radiation alone in multicenter analysis: its usefulness and limitations in clinical practice.
    Kodaira T; Fuwa N; Toita T; Nomoto Y; Kuzuya K; Tachibana K; Furutani K; Ogawa K
    Am J Clin Oncol; 2003 Dec; 26(6):574-83. PubMed ID: 14663375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma.
    Morice P; Castaigne D; Pautier P; Rey A; Haie-Meder C; Leblanc M; Duvillard P
    Gynecol Oncol; 1999 Apr; 73(1):106-10. PubMed ID: 10094889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer of the cervix stage Ib and IIa: survival related to treatment and histopathological risk factors.
    Ngan HY; Obradovic D; Krauer F
    Eur J Surg Oncol; 1988 Jun; 14(3):203-8. PubMed ID: 3371471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
    Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
    Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
    Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracapsular extension of pelvic lymph node metastases is of prognostic value in carcinoma of the cervix uteri.
    Horn LC; Hentschel B; Galle D; Bilek K
    Gynecol Oncol; 2008 Jan; 108(1):63-7. PubMed ID: 17920109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of micrometastases in pelvic lymph nodes in patients with carcinoma of the cervix uteri using step sectioning: Frequency, topographic distribution and prognostic impact.
    Horn LC; Hentschel B; Fischer U; Peter D; Bilek K
    Gynecol Oncol; 2008 Nov; 111(2):276-81. PubMed ID: 18722005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pelvic lymph node invasion in cancer of the uterine cervix].
    Renolleau C; Laroussinie MP; Mosseri V; Fenton J; de la Rochefordière A; Clough KB; Hamelin JP; Durand JC
    Bull Cancer; 1995; 82(5):377-83. PubMed ID: 7626846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment tumour volume measurement on high-resolution magnetic resonance imaging as a predictor of survival in cervical cancer.
    Soutter WP; Hanoch J; D'Arcy T; Dina R; McIndoe GA; DeSouza NM
    BJOG; 2004 Jul; 111(7):741-7. PubMed ID: 15198766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer.
    Fyles A; Milosevic M; Pintilie M; Syed A; Levin W; Manchul L; Hill RP
    Radiother Oncol; 2006 Aug; 80(2):132-7. PubMed ID: 16920212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The degree of circumferential tumour involvement as a prognostic factor in oesophageal cancer.
    Sillah K; Pritchard SA; Watkins GR; McShane J; West CM; Page R; Welch IM
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):368-73. PubMed ID: 19318270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
    Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
    Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.